PBE:NYE-Invesco Dynamic Biotechnology & Genome ETF (USD)

ETF | Health |

Last Closing

USD 69.2746

Change

0.00 (0.00)%

Market Cap

N/A

Volume

2.48K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-20 )

ETFs Containing PBE

WBIR 0.00 % 1.25 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 5.22% 52% F 44% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 5.22% 52% F 48% F
Trailing 12 Months  
Capital Gain 25.04% 71% C- 59% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 25.04% 71% C- 61% D-
Trailing 5 Years  
Capital Gain 38.00% 71% C- 68% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 38.00% 71% C- 68% D+
Average Annual (5 Year Horizon)  
Capital Gain 6.02% 52% F 58% F
Dividend Return 6.03% 48% F 50% F
Total Return 0.01% 11% F 1% F
Risk Return Profile  
Volatility (Standard Deviation) 20.96% 43% F 50% F
Risk Adjusted Return 28.79% 48% F 46% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.